# US 2010/0167312 A1 · Method for assaying a target analyte while reducing interference in an immunosensor system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167312 A1
- Document ID: US20100167312A1
- Status: Published application
- Kind: A1
- Application number: 12/708,429
- Filed: 2010-02-18
- Published: 2010-07-01
- Earliest claimed: 2003-09-10
- Assignees: Abbott Point of Care Inc.
- Inventors: Cary James Miller; John Lewis Emerson Campbell
- Web page: https://patentgrep.com/patent/US20100167312A1

## CPC

- G01N 33/5438: {Electrodes}
- Y10S 436/807: Apparatus included in process claim, e.g. physical support structures
- Y10T 436/25: including sample preparation
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

An electrochemical immunosensor system with reduced interference, comprising: a first immunosensor that generates an electrochemical signal based on the formation of a sandwich between an immobilized antibody, a target analyte and a labeled antibody, wherein a portion of the signal arises from non-specific binding of the labeled antibody in the region of the first immunosensor, and a second immunosensor that acts as an immuno-reference sensor and generates a signal that is the same as or predictably related to the degree of non-specific binding which occurs in the region of the first immunosensor, and has an immunocomplex between an immobilized antibody and an endogenous or exogenous protein that is in the sample and that is not the target analyte.

## Claims

### Claim at position 1

1-68. (canceled)

### Claim 69

A method for assaying a target analyte while reducing interference in an immunosensor system, comprising:
contacting a sample containing a target analyte plus an endogenous or exogenous protein, which is not the target analyte, with an immunosensor system comprising
a first immunosensor that generates a signal based on the formation of a sandwich between an immobilized antibody, a target analyte and a labeled antibody, wherein a portion of the signal arises from a degree of non-specific binding of the labeled antibody in the region of the first immunosensor,
a second immunosensor that acts as an immuno-reference sensor and generates a signal that is the same as or predictably related to the degree of non-specific binding which occurs in the region of the first immunosensor, and has an immunocomplex between an immobilized antibody and said endogenous or exogenous protein,
washing said first and second immunosensors with a wash fluid, and
using a subtraction analyzer, the signal from the first immunosensor, and the signal from the second immunosensor to determine a corrected analyte concentration in the sample.

### Claim 70 (depends on 69)

The method of claim 69, wherein the first and second immunosensors are electrochemical sensors.

### Claim 71 (depends on 69)

The method of claim 69, wherein the first and second immunosensors are amperometric electrochemical sensors.

### Claim 72 (depends on 69)

The method of claim 69, wherein the first and second immunosensors are selected from the group consisting of potentiometric sensors, field effect transistor sensors, conductimetric sensors, optical sensors, evanescent wave sensors, optical wave guides, thermometric sensors and acoustic wave sensors.

### Claim 73 (depends on 69)

The method of claim 69, wherein the system is in a disposable cartridge for measuring analytes in a sample.

### Claim 74 (depends on 69)

The method of claim 69, wherein the target analyte is selected from the group consisting of troponin I, troponin T, creatine kinase MB, procalcitonin, hCG, NTproBNP, proBNP, BNP and myoglobin.

### Claim 75 (depends on 69)

The method of claim 69, wherein the immobilized antibody in the second immunosensor is to a plasma protein.

### Claim 76 (depends on 69)

The method of claim 69, wherein the immobilized antibody in the second immunosensor is to a protein selected from the group consisting of human serum albumin (HAS), bovine serum albumin (BSA), fibrinogen and IgG fc region.

### Claim 77 (depends on 69)

The method of claim 69, wherein the endogenous or exogenous protein in the sample is present at a concentration sufficient to bind more than 50% of the available immobilized antibody on the second immunosensor within about 100 seconds of the sample contacting the immunosensor system.

### Claim 78 (depends on 69)

The method of claim 69, wherein the immobilized antibody in the second immunosensor has an affinity constant of about 1×10−7 to 1×10−15.

### Claim 79 (depends on 69)

The method of claim 69, wherein the endogenous protein is HAS in a concentration of about 100 ng/ml or more.

### Claim 80 (depends on 69)

The method of claim 69, wherein the endogenous or exogenous protein is present in a blood sample at a concentration of at least three orders of magnitude above the affinity constant of the antibody in the second immunosensor.

### Claim 81 (depends on 69)

The method of claim 69, wherein both antibodies are immobilized on microparticles of diameter in the range 0.01 μm-5.0 μm.

### Claim 82 (depends on 81)

The method of claim 81, wherein the microparticle is a carboxylate modified polystyrene bead.

### Claim 83 (depends on 69)

The method of claim 69, wherein the signals from the first and second immunosensors are used to monitor the washing efficiency.

### Claim 84 (depends on 69)

The method of claim 69, wherein the signals from the first and second immunosensors are used to detect anomalous sample conditions including improperly anti-coagulated samples.
